EUROPROTEOME AG
Europroteome AG develops diagnostic, immunological, and prognostic tools as well as patient-specific therapies for human epithelial cancers.
EUROPROTEOME AG
Industry:
Biotechnology
Founded:
1998-01-01
Address:
Hennigsdorf, Brandenburg, Germany
Country:
Germany
Status:
Active
More informations about "Europroteome AG"
Europroteome AG - Company Profile and News - Bloomberg …
Company profile page for Europroteome AG including stock price, company news, executives, board members, and contact informationSee details»
Europroteome - Products, Competitors, Financials, Employees ...
Europroteome was founded in 1998. Where is Europroteome's headquarters? Europroteome's headquarters is located at Neuendorfstrasse 24a, Hennigsdorf. What is Europroteome's latest …See details»
Europroteome AG | Insights
Mar 1, 2004 Europroteome AG. Industry. Biotechnology. Drug Discovery Technologies. Genomics-Proteomics; Bioinformatics; Large Molecule; Pharmaceuticals; In Vitro Diagnostics. …See details»
Europroteome AG - Tech Stack, Apps, Patents & Trademarks
Europroteome AG develops diagnostic, immunological, and prognostic tools.See details»
EUROPROTEOME announces collaboration with Altana Pharma in …
Jul 2, 2004 EUROPROTEOME AG announced that it has entered into a collaboration for evaluation of approaches for molecular profiling of tissue specimens from cancer patients with …See details»
Silvia Tortola - Member Of The Clinical Research Ethical ... - The Org
Previously, Silvia held positions as a Staff Scientist at EUROPROTEOME AG from April 2002 to November 2004, a Researcher at Fondation pour Recherches Médicales Université de …See details»
Europroteome AG acquired by Luminor Medical Technologies
Europroteome AG acquired by Luminor Medical Technologies . Save . Summary. Overview. Edit Overview Section. Acquired Organization: Europroteome AG Europroteome AG develops …See details»
Europroteome AG: Drug pipelines, Patents, Clinical trials - Synapse
Explore Europroteome AG with its drug pipeline, therapeutic area, technology platform, 5 literature, Drug:EP-6797, EP-2321, EP-3212.See details»
Europroteome AG - BioCentury Company Profiles - BCIQ
Europroteome AG - BioCentury Company Profiles for the biopharma industrySee details»
EuroProteome Raises EUR9.5M To Fund Work In Cancer Proteins
Sep 26, 2001 BORNHEIM, Germany ¿ EuroProteome AG completed its second financing round, raising EUR9.5 million (US$8.77 million). With the proceeds, Hennigsdorf, Germany-based …See details»
Proteome Analysis for the Identification of Tumor-Associated …
Feb 2, 2004 a Europroteome AG, Berlin-Hennigsdorf, b Department of Surgery, c Institute of Pathology, and d Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto …See details»
EP-2321 - Drug Targets, Indications, Patents - Synapse
EP-2321, Initially developed by Europroteome AG, Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms. Biomedical products. Data. Feature. Plans. Sign Up for Free. …See details»
Identification of the Thrombin Light Chain A as the Single Best …
Mar 4, 2005 Gastric cancer mortality is second only to lung cancer, and its prognosis is dismal. Using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry, we …See details»
Identification of Gastric Cancer Patients by Serum Protein Profiling ...
Using surface-enhanced laser desorption ionization mass spectrometry (SELDI/TOF−MS) and ProteinChip technology, coupled with a pattern-matching algorithm and serum samples, we …See details»
Harnessing the Power of Genomics and Proteomics
Sep 21, 2012 Europroteome AG applies state-of-the-art, convergent gene expression technologies, proteomics and transcriptomics to human epithelial cancers (e.g. colon or lung …See details»
DIFFERENTIAL DIAGNOSIS OF COLORECTAL CANCER AND OTHER …
May 17, 2004 Europe PMC is an archive of life sciences journal literature.See details»
Assessment of the biological performance of the needle‐free …
Mar 1, 2004 The World Health Organization estimates that 12 billion hypodermic injections are given in healthcare settings around the world each year. 1, 2 Accidental needle stick injuries ...See details»
The Role of Proteomics in the Diagnosis and Outcome Prediction …
Europroteome AG Neuendorfer Str 24A D - 16761 HENNIGSDORF Germany See all articles by this author. Search Google Scholar for this author, H. Lippert, M.D. 1. H. Lippert . Dept of …See details»
EP-6797 - Drug Targets, Indications, Patents - Synapse - Patsnap
Europroteome AG. Drug Highest Phase Pending Preclinical. First Approval Date-Regulation-Related. 100 Clinical Results associated with EP-6797. Login to view more data. 100 …See details»